Skip to content
Menu

Metagenomi Therapeutics, Inc. MGX

Full chart Compare
Set alert

Price alert · MGX

All alert types
0.61 USD -0.02 (-2.71%)

As ofNov 19, 2026, 3:49 PM EST

0.61 Day range 0.6423
0.60 52-week range 1.87
YTD
-62.06%
1 year
-61.82%

Revenue & Expenses

Revenue Profit Costs
Other Income$8.09MOther Operating Income$5.32MIncome Tax Benefit$58.00KGross Profit$19.89MNet Loss$87.87MCost of Revenue$5.32MExpenses$121.22MSelling, General & Admin$26.79MResearch & Development$94.43MRevenue$25.21M

Latest period ending Dec 31, 2025 · select a line to chart its full history

MGX annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
25.21M52.30M44.76M17.20M243.00K
25.21M52.30M44.76M17.20M243.00K
-96.01M-88.90M-78.49M-44.64M-23.95M
-87.87M-78.06M-68.25M-43.59M-21.44M
-2.36-2.36-20.05-12.82-6.58
MGX annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
46.91M32.63M145.85M190.51M43.40M
221.10M324.60M364.84M414.49M141.99M
62.51M89.74M149.67M142.81M98.04M
40.66M45.78M48.23M18.57M48.93M
158.60M234.86M-135.58M-74.43M-32.54M
MGX annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-88.89M-109.07M-91.41M29.72M24.26M
103.53M-88.16M45.73M-122.20M-74.32M
-356.00K84.01M1.01M239.59M39.92M
-537.00K-3.11M-9.81M-13.98M-2.90M
14.28M-113.22M-44.66M147.12M-10.14M